{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:33:26Z","timestamp":1782387206422,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12401-4","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T11:15:10Z","timestamp":1766661310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictors of 30-day mortality in critically ill patients with bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: a five-year retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Mei-Yuan","family":"Teo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaw-Woei","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chung","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Pang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jer","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang-Pin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chin","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chung","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"issue":"11","key":"12401_CR1","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.jfma.2021.04.014","volume":"120","author":"JY Hsu","year":"2021","unstructured":"Hsu JY, Chuang YC, Wang JT, Chen YC, Hsieh SM. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: risk factors, mortality, and antimicrobial susceptibility, 2017\u20132019. J Formos Med Assoc. 2021;120(11):1994\u20132002.","journal-title":"J Formos Med Assoc"},{"issue":"11","key":"12401_CR2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1017\/ice.2017.197","volume":"38","author":"PP Kohler","year":"2017","unstructured":"Kohler PP, Volling C, Green K, Uleryk EM, Shah PS, McGeer A. Carbapenem Resistance, initial antibiotic Therapy, and mortality in Klebsiella pneumoniae bacteremia: A systematic review and Meta-Analysis. Infect Control Hosp Epidemiol. 2017;38(11):1319\u201328.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"12401_CR3","doi-asserted-by":"crossref","unstructured":"Satlin MJ, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim AC et al. Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant enterobacteriaceae (CRE) in the CRE epicenter of the United States. Antimicrob Agents Chemother 2017;61(4).","DOI":"10.1128\/AAC.02349-16"},{"key":"12401_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drup.2016.09.002","volume":"29","author":"RF Potter","year":"2016","unstructured":"Potter RF, D\u2019Souza AW, Dantas G. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resist Updat. 2016;29:30\u201346.","journal-title":"Drug Resist Updat"},{"key":"12401_CR5","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.3389\/fmicb.2018.02888","volume":"9","author":"SS Jean","year":"2018","unstructured":"Jean SS, Lee NY, Tang HJ, Lu MC, Ko WC, Hsueh PR. Carbapenem-Resistant Enterobacteriaceae infections: Taiwan aspects. Front Microbiol. 2018;9:2888.","journal-title":"Front Microbiol"},{"issue":"7","key":"12401_CR6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3201\/eid2007.121004","volume":"20","author":"ME Falagas","year":"2014","unstructured":"Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20(7):1170\u20135.","journal-title":"Emerg Infect Dis"},{"key":"12401_CR7","doi-asserted-by":"publisher","first-page":"1157010","DOI":"10.3389\/fcimb.2023.1157010","volume":"13","author":"D Li","year":"2023","unstructured":"Li D, Huang X, Rao H, Yu H, Long S, Li Y, Zhang J. Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2023;13:1157010.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"12401_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jmii.2014.05.010","volume":"48","author":"YY Chang","year":"2015","unstructured":"Chang YY, Chuang YC, Siu LK, Wu TL, Lin JC, Lu PL, et al. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect. 2015;48(2):219\u201325.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"12401_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13756-020-0686-0","volume":"9","author":"WM Zhu","year":"2020","unstructured":"Zhu WM, Yuan Z, Zhou HY. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020;9(1):23.","journal-title":"Antimicrob Resist Infect Control"},{"key":"12401_CR10","unstructured":"Taiwan Healthcare-associated. Infection and Antimicrobial Resistance Surveillance Report 2023. 2023."},{"issue":"Suppl 7","key":"12401_CR11","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.1093\/cid\/ciz830","volume":"69","author":"Y Doi","year":"2019","unstructured":"Doi Y. Treatment options for Carbapenem-resistant Gram-negative bacterial infections. Clin Infect Dis. 2019;69(Suppl 7):S565\u201375.","journal-title":"Clin Infect Dis"},{"key":"12401_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3389\/fmicb.2019.01823","volume":"10","author":"X Cui","year":"2019","unstructured":"Cui X, Zhang H, Du H. Carbapenemases in enterobacteriaceae: detection and antimicrobial therapy. Front Microbiol. 2019;10:1823.","journal-title":"Front Microbiol"},{"issue":"2","key":"12401_CR13","doi-asserted-by":"publisher","first-page":"106528","DOI":"10.1016\/j.ijantimicag.2022.106528","volume":"59","author":"YL Lee","year":"2022","unstructured":"Lee YL, Chen HM, Hii IM, Hsueh PR. Carbapenemase-producing enterobacterales infections: recent advances in diagnosis and treatment. Int J Antimicrob Agents. 2022;59(2):106528.","journal-title":"Int J Antimicrob Agents"},{"key":"12401_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jgar.2021.03.024","volume":"25","author":"Z Cherak","year":"2021","unstructured":"Cherak Z, Loucif L, Moussi A, Rolain JM. Carbapenemase-producing Gram-negative bacteria in aquatic environments: a review. J Glob Antimicrob Resist. 2021;25:287\u2013309.","journal-title":"J Glob Antimicrob Resist"},{"key":"12401_CR15","doi-asserted-by":"crossref","unstructured":"Bush K, Bradford PA. Epidemiology of \u03b2-lactamase-producing pathogens. Clin Microbiol Rev 2020;33(2).","DOI":"10.1128\/CMR.00047-19"},{"key":"12401_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fcimb.2020.00314","volume":"10","author":"R Han","year":"2020","unstructured":"Han R, Shi Q, Wu S, Yin D, Peng M, Dong D, et al. Dissemination of carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among Carbapenem-Resistant Enterobacteriaceae isolated from adult and children patients in China. Front Cell Infect Microbiol. 2020;10:314.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6 Pt 2","key":"12401_CR17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jmii.2021.10.008","volume":"55","author":"AY Wu","year":"2022","unstructured":"Wu AY, Chang H, Wang NY, Sun FJ, Liu CP. Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia. J Microbiol Immunol Infect. 2022;55(6 Pt 2):1229\u201338.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"12401_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/07853890.2022.2152484","volume":"55","author":"DR Giacobbe","year":"2023","unstructured":"Giacobbe DR, Di Pilato V, Karaiskos I, Giani T, Marchese A, Rossolini GM, Bassetti M. Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades. Ann Med. 2023;55(1):101\u201313.","journal-title":"Ann Med"},{"issue":"7","key":"12401_CR19","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s001340050931","volume":"25","author":"R Moreno","year":"1999","unstructured":"Moreno R, Vincent JL, Matos R, Mendon\u00e7a A, Cantraine F, Thijs L, et al. The use of maximum SOFA score to quantify organ dysfunction\/failure in intensive care. Results of a prospective, multicentre study. Intensive Care Med. 1999;25(7):686\u201396. Working Group on Sepsis related Problems of the ESICM.","journal-title":"Intensive Care Med"},{"issue":"7","key":"12401_CR20","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s00134-023-07108-6","volume":"49","author":"M Jeffrey","year":"2023","unstructured":"Jeffrey M, Denny KJ, Lipman J, Conway Morris A. Differentiating infection, colonisation, and sterile inflammation in critical illness: the emerging role of host-response profiling. Intensive Care Med. 2023;49(7):760\u201371.","journal-title":"Intensive Care Med"},{"issue":"12","key":"12401_CR21","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/j.1469-0691.2011.03514.x","volume":"17","author":"O Zarkotou","year":"2011","unstructured":"Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17(12):1798\u2013803.","journal-title":"Clin Microbiol Infect"},{"key":"12401_CR22","doi-asserted-by":"crossref","unstructured":"Shields RK, Nguyen MH, Chen L, Press EG, Potoski BA, Marini RV et al. Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother 2017;61(8).","DOI":"10.1128\/AAC.00883-17"},{"issue":"1","key":"12401_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13054-020-2742-9","volume":"24","author":"M Falcone","year":"2020","unstructured":"Falcone M, Bassetti M, Tiseo G, Giordano C, Nencini E, Russo A, et al. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care. 2020;24(1):29.","journal-title":"Crit Care"},{"issue":"5","key":"12401_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.cmi.2016.01.016","volume":"22","author":"M Falcone","year":"2016","unstructured":"Falcone M, Russo A, Iacovelli A, Restuccia G, Ceccarelli G, Giordano A, et al. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Microbiol Infect. 2016;22(5):444\u201350.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"12401_CR25","first-page":"e0775","volume":"4","author":"J Prest","year":"2022","unstructured":"Prest J, Nguyen T, Rajah T, Prest AB, Sathananthan M, Jeganathan N. Sepsis-Related mortality rates and trends based on site of infection. Crit Care Explor. 2022;4(10):e0775.","journal-title":"Crit Care Explor"},{"key":"12401_CR26","first-page":"100972","volume":"43","author":"C Zhang","year":"2024","unstructured":"Zhang C, Fu X, Liu Y, Zhao H, Wang G. Burden of infectious diseases and bacterial antimicrobial resistance in china: a systematic analysis for the global burden of disease study 2019. Lancet Reg Health West Pac. 2024;43:100972.","journal-title":"Lancet Reg Health West Pac"},{"issue":"6","key":"12401_CR27","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jmii.2020.03.018","volume":"53","author":"CM Kang","year":"2020","unstructured":"Kang CM, Chen XJ, Chih CC, Hsu CC, Chen PH, Lee TF, et al. Rapid identification of bloodstream bacterial and fungal pathogens and their antibiotic resistance determinants from positively flagged blood cultures using the biofire filmarray blood culture identification panel. J Microbiol Immunol Infect. 2020;53(6):882\u201391.","journal-title":"J Microbiol Immunol Infect"},{"key":"12401_CR28","doi-asserted-by":"crossref","unstructured":"Falsey AR, Branche AR, Croft DP, Formica MA, Peasley MR, Walsh EE. Real-life assessment of biofire filmArray\u00ae pneumonia panel in adults hospitalized with respiratory illness. J Infect Dis. 2024;229(1):214\u201322.","DOI":"10.1093\/infdis\/jiad221"},{"issue":"12","key":"12401_CR29","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/cid\/ciac354","volume":"75","author":"MJ Satlin","year":"2022","unstructured":"Satlin MJ, Chen L, Gomez-Simmonds A, Marino J, Weston G, Bhowmick T, et al. Impact of a rapid molecular test for Klebsiella pneumoniae carbapenemase and Ceftazidime-Avibactam use on outcomes after bacteremia caused by Carbapenem-Resistant enterobacterales. Clin Infect Dis. 2022;75(12):2066\u201375.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"12401_CR30","doi-asserted-by":"publisher","first-page":"e0260321","DOI":"10.1128\/spectrum.02603-21","volume":"10","author":"Y Chen","year":"2022","unstructured":"Chen Y, Huang HB, Peng JM, Weng L, Du B. Efficacy and safety of Ceftazidime-Avibactam for the treatment of Carbapenem-Resistant enterobacterales bloodstream infection: a systematic review and Meta-Analysis. Microbiol Spectr. 2022;10(2):e0260321.","journal-title":"Microbiol Spectr"},{"issue":"7","key":"12401_CR31","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1093\/jac\/dkv086","volume":"70","author":"M Tumbarello","year":"2015","unstructured":"Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015;70(7):2133\u201343.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"12401_CR32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/21505594.2017.1292196","volume":"8","author":"EM Trecarichi","year":"2017","unstructured":"Trecarichi EM, Tumbarello M. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections. Virulence. 2017;8(4):470\u201384.","journal-title":"Virulence"},{"issue":"5","key":"12401_CR33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jiph.2024.03.010","volume":"17","author":"W Katip","year":"2024","unstructured":"Katip W, Rayanakorn A, Oberdorfer P, Taruangsri P, Nampuan T, Okonogi S. Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis. J Infect Public Health. 2024;17(5):727\u201334.","journal-title":"J Infect Public Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12401-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12401-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12401-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:57:02Z","timestamp":1769518622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12401-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12401"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12401-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Institutional Review Board of Chang Gung Memorial Hospital (Approval number: 201801433B0). Written informed consent for participation was not required for this study in accordance with national legislation and the institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}